ORCHPHARMA Financial Statements

ORCHPHARMA Annual Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (11) (26) (14) (8.80)
Op profit growth (295) (262) (309) (104)
EBIT growth (65) 30.40 (20) (340)
Net profit growth (11) (63) (29) 77.50
Profitability ratios (%)        
OPM 11.10 (5) 2.30 (0.90)
EBIT margin (9.80) (25) (14) (15)
Net profit margin (26) (26) (52) (62)
RoCE (3.10) (6.30) (3.70) (4)
RoNW (4.10) 254 14 59.30
RoA (2.10) (1.60) (3.40) (4.10)
Per share ratios ()        
EPS (29) (32) -- --
Dividend per share -- -- -- --
Cash EPS (55) (63) (55) (72)
Book value per share 160 188 (89) (52)
Valuation ratios        
P/E (86) -- -- --
P/CEPS (45) -- (0.20) (0.40)
P/B 15.40 -- (0.10) (0.50)
EV/EBIDTA 161 -- 83.20 156
Payout (%)        
Dividend payout -- -- -- --
Tax payout -- -- (12) (11)
Liquidity ratios        
Debtor days 82.60 67.30 75.90 109
Inventory days 119 120 108 104
Creditor days (96) (157) (217) (183)
Leverage ratios        
Interest coverage 0.86 30.50 0.32 0.36
Net debt / equity 0.66 0.51 (3.70) (6.10)
Net debt / op. profit 8.70 (15) 185 (379)
Cost breakup ()        
Material costs (51) (48) (51) (49)
Employee costs (15) (17) (13) (10)
Other costs (23) (40) (34) (42)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 450 508 683 797
yoy growth (%) (11) (26) (14) (8.80)
Raw materials (229) (243) (350) (393)
As % of sales 50.80 47.90 51.30 49.40
Employee costs (67) (85) (86) (79)
As % of sales 14.90 16.70 12.60 9.97
Other costs (105) (205) (231) (331)
As % of sales 23.30 40.40 33.80 41.60
Operating profit 49.80 (25) 15.70 (7.50)
OPM 11.10 (5) 2.30 (0.90)
Depreciation (109) (126) (133) (141)
Interest expense (51) (4.20) (302) (336)
Other income 15.20 24.50 20.30 27.30
Profit before tax (95) (131) (399) (458)
Taxes -- -- 46.20 48.30
Tax rate -- -- (12) (11)
Minorities and other (21) -- -- --
Adj. profit (117) (131) (353) (409)
Exceptional items -- -- -- (86)
Net profit (117) (131) (353) (495)
yoy growth (%) (11) (63) (29) 77.50
NPM (26) (26) (52) (62)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (95) (131) (399) (458)
Depreciation (109) (126) (133) (141)
Tax paid -- -- 46.20 48.30
Working capital (594) (177) (223) (758)
Other operating items -- -- -- --
Operating cashflow (798) (434) (709) (1,308)
Capital expenditure (1,438) (1,843) (2,253) (1,365)
Free cash flow (2,236) (2,276) (2,962) (2,673)
Equity raised 1,698 1,888 (200) 188
Investments 14.60 (0.50) 0.12 0.33
Debt financing/disposal (1,627) (1,439) 1,733 347
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash (2,150) (1,827) (1,429) (2,138)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 40.80 40.80 89 89
Preference capital -- -- -- --
Reserves 612 725 (793) (881)
Net worth 653 766 (704) (792)
Minority interest
Debt 453 566 3,230 3,202
Deferred tax liabilities (net) 153 201 244 97.40
Total liabilities 1,258 1,533 2,769 2,508
Fixed assets 678 884 1,534 1,658
Intangible assets
Investments 15.40 0.34 0.47 1.07
Deferred tax asset (net) 149 198 240 94.10
Net working capital 396 278 669 449
Inventories 153 142 170 194
Inventory Days 124 102 -- 104
Sundry debtors 136 68 120 120
Debtor days 110 48.80 -- 63.90
Other current assets 235 192 927 848
Sundry creditors (110) (102) (302) (359)
Creditor days 89.20 73 -- 192
Other current liabilities (18) (23) (245) (353)
Cash 19.90 174 326 306
Total assets 1,258 1,533 2,769 2,508
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018
Gross Sales 560 450 484 600 688
Excise Duty -- -- -- -- 4.83
Net Sales 560 450 484 600 683
Other Operating Income -- -- -- -- --
Other Income 67.50 15.20 24.30 218 20.30
Total Income 627 465 508 818 703
Total Expenditure ** 510 422 517 618 667
PBIDT 117 43.70 (8.90) 200 36
Interest 32 51.30 4.16 0.30 302
PBDT 85.10 (7.60) (13) 199 (266)
Depreciation 87 109 118 130 133
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- --
Deferred Tax -- -- -- -- (46)
Reported Profit After Tax (2) (117) (131) 69.40 (353)
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest (2) (117) (131) 69.40 (353)
Extra-ordinary Items -- -- -- 201 --
Adjusted Profit After Extra-ordinary item (2) (117) (131) (132) (353)
EPS (Unit Curr.) (0.50) (29) (32) 7.80 (40)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 40.80 40.80 40.80 89 89
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 20.90 9.71 (1.80) 33.30 5.27
PBDTM(%) 15.20 (1.70) (2.70) 33.20 (39)
PATM(%) (0.30) (26) (27) 11.60 (52)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity